Career Enhancement Program
Career Enhancement Program
批准号:
10554480
负责人:
MATS LJUNGMAN
金额:
$9.57万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-14 至 2028-07-31
关键词:
Applications GrantsAreaArticulationBasic ScienceCancer BiologyCancer PatientClinical TrialsClinical Trials DesignConduct Clinical TrialsCorrelative StudyDevelopmentEarly identificationEducational CurriculumEnsureEthnic PopulationEvidence based practiceFacultyFosteringFunding MechanismsGoalsGrantHealth SciencesIndividualLaboratoriesLeadershipLifeLocally Advanced Malignant NeoplasmManuscriptsMeasuresMediationMentorsMentorshipMichiganMinority GroupsMinority-Serving InstitutionMolecular TargetMonitorParticipantPatient CarePeer ReviewPreclinical TestingQualifyingRadiationRadiobiologyRadiosensitizationReportingResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesScientistTestingTrainingTraining SupportTranslatingTranslational ResearchTranslationsUniversitiesWomanWorkWritinganticancer researchcareercareer developmentclinical practiceexpectationexperiencehealth equityinterestleadership developmentmembernovelnovel strategiespeerpreclinical studyprogramsracial populationsenior facultyskillssuccesssupport networktranslational potentialtranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT (CAREER ENHANCEMENT PROGRAM)
The Career Enhancement Program (CEP) of the Molecularly Targeted Radiosensitization of Locally
Advanced Cancers SPORE at the University of Michigan seeks to identify and foster a trained and engaged
pool of investigators focused on studies of molecularly targeted radiosensitization. Translating basic
discoveries into clinical practice remains a major challenge to the implementation of many promising
funding mechanisms. Accordingly, our program strives to identify and mentor a diverse group of scientists
committed to engaging in this challenge. We firmly believe that progress in translational research is
dependent on supporting and enhancing early career development of investigators committed to make a
difference in cancer patients’ lives. The CEP identifies early career investigators who demonstrate excellent
progress towards achieving independence, as well as established investigators interested in transitioning
their research program to translation of radiation cancer biology to patient care, and senior investigators
with cancer research experience who desire to develop additional expertise in translational science.
Examples of the latter are basic science investigators who plan to test the translation of their studies first in
pre-clinical testing followed by clinical trials. Similarly, clinicians conducting clinical trials who plan to
develop novel approaches grounded in the laboratory but who do not have basic science expertise or a wet
lab in which to conduct necessary preclinical and correlative studies are also considered. A high priority of
the CEP is to identify, support and mentor members of groups traditionally under-represented in academic
health sciences. The SPORE will employ evidence-based practices to encourage proposals from faculty
who are members of groups traditionally under-represented, including women and those from under-
represented racial and ethnic groups, among others. In addition, the SPORE will develop relationships that
will enable identification and encourage proposals from groups traditionally underrepresented in academic
health sciences from nearby institutions that serve minority populations. SPORE leadership and
investigators will encourage best practices to ensure successful mentorship and career development of
participants. Mentoring teams will include experienced mentors who will also be provided with formal
training in both mentorship and sponsorship. The program will articulate clear expectations and goals for
career development and mentoring relationships. It will support participants’ professional development in
areas like clinical trial design and grant writing; it will also offer real-world opportunities for honing
presentation and networking skills in the SPORE annual retreats. The CEP curriculum will target skills in
areas like negotiation, work-life integration, and leadership development, encouraging peer mentorship in
addition to the other forms of mentorship established in the program. Impact will be carefully measured
and evaluated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Precision targeting of bladder cancer using CRISPR technology
-
批准号:10442573
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2021
-
负责人:MATS LJUNGMAN
-
依托单位:
Mapping of Novel Candidate Functional Elements with Bru-Seq Technology
-
批准号:10240972
-
项目类别:
-
资助金额:$46.05万
-
财政年份:2021
-
负责人:MATS LJUNGMAN
-
依托单位:
Precision targeting of bladder cancer using CRISPR technology
-
批准号:10289763
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2021
-
负责人:MATS LJUNGMAN
-
依托单位:
Targeting the RNA Exosome for Cancer Therapeutics
-
批准号:10684671
-
项目类别:
-
资助金额:$47.96万
-
财政年份:2019
-
负责人:MATS LJUNGMAN
-
依托单位:
Targeting the RNA Exosome for Cancer Therapeutics
-
批准号:10208799
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2019
-
负责人:MATS LJUNGMAN
-
依托单位:
Targeting the RNA Exosome for Cancer Therapeutics
-
批准号:10462596
-
项目类别:
-
资助金额:$47.96万
-
财政年份:2019
-
负责人:MATS LJUNGMAN
-
依托单位:
Mapping of Novel Candidate Functional Elements with Bru-Seq Technology
-
批准号:9246747
-
项目类别:
-
资助金额:$47.97万
-
财政年份:2017
-
负责人:MATS LJUNGMAN
-
依托单位:
Travel Awards for the 4th Asian Conference on Environmental Mutagens
-
批准号:8837932
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2014
-
负责人:MATS LJUNGMAN
-
依托单位:
2013 Environmental Mutagen Society Annual Meeting
-
批准号:8856573
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2013
-
负责人:MATS LJUNGMAN
-
依托单位:
2013 Environmental Mutagen Society Annual Meeting
-
批准号:8737903
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2013
-
负责人:MATS LJUNGMAN
-
依托单位:
2013 Environmental Mutagen Society Annual Meeting
-
批准号:8594353
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2013
-
负责人:MATS LJUNGMAN
-
依托单位:
Development and Validation of BruChase-Seq and BrUV-Seq
-
批准号:8464184
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2012
-
负责人:MATS LJUNGMAN
-
依托单位:
Development and Validation of BruChase-Seq and BrUV-Seq
-
批准号:8310663
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2012
-
负责人:MATS LJUNGMAN
-
依托单位:
Development and Validation of BruChase-Seq and BrUV-Seq
-
批准号:8628859
-
项目类别:
-
资助金额:$38.23万
-
财政年份:2012
-
负责人:MATS LJUNGMAN
-
依托单位:
Mechanisms of Genotoxic Stress-regulated Gene Expression in Human Cells
-
批准号:8462978
-
项目类别:
-
资助金额:$19.05万
-
财政年份:2012
-
负责人:MATS LJUNGMAN
-
依托单位:
Environmental Mutagen Society 2012 Annual Meeting-Trainee and Speaker Support
-
批准号:8395922
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2012
-
负责人:MATS LJUNGMAN
-
依托单位:
Mechanisms of Genotoxic Stress-regulated Gene Expression in Human Cells
-
批准号:8302710
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2012
-
负责人:MATS LJUNGMAN
-
依托单位:
Targeting ATDC with PARP inhibitors in pancreatic cancer
-
批准号:7875693
-
项目类别:
-
资助金额:$16.45万
-
财政年份:2010
-
负责人:MATS LJUNGMAN
-
依托单位:
Targeting ATDC with PARP inhibitors in pancreatic cancer
-
批准号:8061692
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2010
-
负责人:MATS LJUNGMAN
-
依托单位:
11th Annual Midwest DNA Repair Symposium
-
批准号:7673212
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2009
-
负责人:MATS LJUNGMAN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: